ArticleMedicine2025
The diagnostic value of magnifying endoscopy with blue light imaging in early gastric cancer.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Magnifying endoscopy with blue laser imaging (ME-BLI) is a novel image-enhanced endoscopic technique utilizing a laser light source optimized for narrow-band observation. This study aimed to evaluate the efficacy of ME-BLI in diagnosing early gastric neoplastic lesions. From July 2022 to June 2024, 288 patients at the First Affiliated Hospital of Guilin Medical University were enrolled. All participants underwent conventional white-light endoscopy followed by ME-BLI examination and targeted biopsy. Pathological results identified 21 cases as early gastric cancer (GC) and 67 as non-early GC. Comparative analysis revealed that the presence of a demarcation line (DL), irregular microvessels (MV), and irregular microsurface structure (MS) was significantly more frequent in the early GC group than in the non-early GC group (all P < .001). The combination of DL, MV, and MS demonstrated high diagnostic performance for early GC, with an area under the curve of 0.875. In conclusion, ME-BLI is a valuable tool for the diagnosis of early GC, and the combined assessment of DL, MV, and MS provides an objective, user-friendly, and reproducible approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.